Ausgabe 1/2023
Inhalt (6 Artikel)
COVID-19
Anaphylaxis and Drug Allergy (M Castells, Section Editor)
Utilizing Biologics in Drug Desensitization
Barbara C. Yang, Mariana C. Castells
Anaphylaxis and Drug Allergy (M Castells, Section Editor)
Disparities in the Diagnosis and Management of Anaphylaxis
Brit Trogen, Samantha Jacobs, Julie Wang
Anaphylaxis and Drug Allergy (M Castells, Section Editor)
Management of Anaphylaxis During Peanut Oral Immunotherapy
Vibha Szafron, Aikaterini Anagnostou
Open Access
Allergens (RK Bush and S Vieths, Section Editors)
Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Disease-Specific Findings (Part 1)
A. Goretzki, J. Zimmermann, H. Rainer, Y.-J. Lin, Stefan Schülke
Open Access
Allergens (RK Bush and S Vieths, Section Editors)
Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Cell Type-Specific Findings (Part 2)
Y.-J. Lin, A. Goretzki, H. Rainer, J. Zimmermann, Stefan Schülke
Open Access
Allergens (RK Bush and S Vieths, Section Editors)
Human Monoclonal IgE Antibodies—a Major Milestone in Allergy
Scott A. Smith, Maksymilian Chruszcz, Martin D. Chapman, Anna Pomés